Dark

Check out our API

ABCM
Abcam plc
stock NASDAQ

Inactive

Dec 5, 2023

23.99USD+0.042%(+0.01)7,430,229

Pre-market

0.00USD-100.000%(-23.98)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 4, 2022

04:04AM EST Alamar Biosciences And Abcam Announce Strategic Partnership RTTNews

04:00AM EST Alamar Biosciences partners with Abcam to drive understanding of the human PR Newswire

Nov 2, 2021

10:56AM EDT Nautilus Biotechnology And Abcam Announce Supply Agreement For Abcam To Provide Nautilus With Antibodies; Financial Terms Not Disclosed Benzinga

10:56AM EDT Nautilus, Abcam Announce Strategic Partnership To Accelerate Exploration Of Proteome; Terms Not Disclosed Benzinga

08:03AM EDT Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of PR Newswire

08:02AM EDT Nautilus And Abcam Announce Strategic Development And Supply Partnership RTTNews

08:00AM EDT Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam(AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a strategic development and supply partnership. GlobeNewswire Inc

Oct 27, 2021

02:02AM EDT Abcam Completes $340 Mln Strategic Acquisition And Expands Kit Capacity And Capability RTTNews

02:01AM EDT Abcam completes $340m strategic acquisition and expands kit capacity and PR Newswire

Sep 13, 2021

07:00AM EDT 29% Constant Currency Revenue Growth in H2 as Lab Activity GlobeNewswire Inc

03:58AM EDT Earnings Scheduled For September 13, 2021 Benzinga

Aug 2, 2021

10:15AM EDT UPDATE: SVB Leerink On Abcam: Firm Notes Acquisition Of BioVision For $340M To Drive 'More In-House High Margin Revenue' Through Biochemical & Cell-Based Assays; Expects BioVision To Deliver 80% Gross Margins Given 2020 Operating Profit At $21.9M Benzinga

10:13AM EDT SVB Leerink Maintains Buy Rating On Abcam Plc With $25 Price Target Benzinga

07:38AM EDT Abcam To Acquire Supplier BioVision For $340M In Cash Benzinga

02:00AM EDT Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", the Company or "the Group"), a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire BioVision, Inc. ("BioVision"), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (NKY), for $340 million (the Acquisition). GlobeNewswire Inc

Jul 13, 2021

07:02AM EDT Abcam opens new US facility in Boston, MA PR Newswire

Jun 22, 2021

08:04AM EDT Pionyr And Abcam Extend Collaboration With New Commercial Licensing Agreement To Support Progression Of PY314 RTTNews

08:01AM EDT Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in PR Newswire

Apr 12, 2021

05:00AM EDT -- Building on existing three-year collaboration -- Focusing on co-development of companion and in vitro diagnostic kits to support demand in China GlobeNewswire Inc

Apr 6, 2021

06:29AM EDT Avacta Announces Distribution Agreement With ABCAM To Avacta's Sell SARS-CoV-2 Research ELISA Affimer Reagents Benzinga

06:24AM EDT Avacta Announces Distribution Deal With ABCAM To Sell SARS-CoV-2 Research ELISA Affimer(r) Reagents RTTNews

Mar 24, 2021

07:49AM EDT Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of Research & Development received the CiteAb award for Significant Individual Impact and the Company was recognized as Antibody Supplier Succeeding in Cardiovascular Research. GlobeNewswire Inc

Mar 9, 2021

05:10AM EST SVB Leerink Maintains Outperform on Abcam, Lowers Price Target to $25 Benzinga

Mar 8, 2021

07:00AM EST Abcam plc (Nasdaq: ABCM; AIM: ABC) (Abcam, the Group or the Company), a global leader in the supply of life science research tools, today announces its interim results for the six month period ended 31 December 2020 (H1 2021). GlobeNewswire Inc

Mar 4, 2021

04:00AM EST -- Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou -- Investing in state-of-the-art facilities and equipment to support research, diagnostic and clinical applications GlobeNewswire Inc

Feb 26, 2021

02:00AM EST Abcam plc (AIM: ABC; Nasdaq: ABCM) (Abcam or the Company), a global leader in the supply of life science research tools, will report its Interim Results for the six-month period ended 31 December 2020 at 12.00 p.m. GMT (7.00 a.m. EST) on Monday, March 8, 2021. GlobeNewswire Inc

Feb 17, 2021

07:00AM EST Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8.00 EST / 13.00 GMT. A live webcast of the presentation can be accessed via the IR Calendar page of Abcams Investor Relations website at https://www.abcamplc.com/reports-presentations. GlobeNewswire Inc

Jan 28, 2021

02:00AM EST Abcam plc (AIM: ABC; Nasdaq: ABCM) (Abcam), a global leader in the supply of life science research tools, is delighted to announce the appointments of Bessie Lee and Mark Capone as non-executive Directors with immediate effect. GlobeNewswire Inc

Jan 27, 2021

05:22AM EST SVB Leerink Maintains Outperform on Abcam, Raises Price Target to $26 Benzinga

Jan 11, 2021

07:00AM EST Abcam plc (AIM: ABC; Nasdaq: ABCM) (Abcam), a global leader in the supply of life science research tools, announces the following unaudited trading update ahead of reporting its results on 8 March 2021 for the six months ended 31 December 2020. GlobeNewswire Inc

Dec 8, 2020

07:07AM EST Abcam Opens New 16,000 Sq Ft Purpose-fitted Facility In Fremont, CA RTTNews

07:01AM EST Abcam reveals new cell engineering facility in Bay Area PR Newswire

Nov 16, 2020

10:02AM EST B of A Securities Initiates Coverage On Abcam with Neutral Rating, Announces Price Target of $20 Benzinga

10:00AM EST Benzinga's Top Upgrades, Downgrades For November 16, 2020 Benzinga

08:02AM EST Morgan Stanley Initiates Coverage On Abcam with Equal-Weight Rating, Announces Price Target of $21 Benzinga

07:04AM EST SVB Leerink Initiates Coverage On Abcam with Outperform Rating, Announces Price Target of $22 Benzinga

Nov 9, 2020

10:09AM EST Stocks Trading Near 52-Week Lows Just After Open On Monday, Nov. 9, 2020: ABCM, SOAC, KOR, BVXV, HPR, BIIB, CTRM, TTNP, ASMB Benzinga

Nov 3, 2020

08:35AM EST Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 September 2020 of its final results for the year ended 30 June 2020, the Abcam plc Annual Report and Accounts 2020 (theAnnual Report) have been published today and are available on the Abcam plc website atwww.abcamplc.com. GlobeNewswire Inc

08:30AM EST Abcam plc: Consultation on 2020 LTIP Awards GlobeNewswire Inc

Oct 26, 2020

11:45AM EDT THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 GlobeNewswire Inc

Oct 22, 2020

10:48AM EDT Abcam Shares Open For Trade At $18; IPO Priced At $17.50/Share Benzinga

08:52AM EDT Abcam Shares Will Open For Quote At 9:50 a.m. EDT, Expected To Open For Trade After 10:00 a.m. EDT, IPO Priced At $17.50/Share Benzinga

08:51AM EDT IPOs Happening Today, Thursday, Oct. 22, 2020: TEKKU, ABCM, BLSA, CTAC/U, GHLD, MCFE, RICE/U, YSACU Benzinga

02:00AM EDT Abcam Announces Pricing of Offering on NASDAQ GlobeNewswire Inc

Share